FANCELLI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 825
EU - Europa 731
AS - Asia 247
OC - Oceania 15
AF - Africa 5
SA - Sud America 1
Totale 1.824
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 819
RU - Federazione Russa 383
IT - Italia 110
IE - Irlanda 97
HK - Hong Kong 64
SG - Singapore 64
PL - Polonia 54
CN - Cina 47
SE - Svezia 39
JO - Giordania 29
ID - Indonesia 19
IN - India 19
AU - Australia 15
FI - Finlandia 13
AT - Austria 9
GB - Regno Unito 7
CA - Canada 5
CH - Svizzera 5
NO - Norvegia 5
CI - Costa d'Avorio 4
VN - Vietnam 4
DE - Germania 3
FR - Francia 2
NL - Olanda 2
BE - Belgio 1
CL - Cile 1
EG - Egitto 1
MX - Messico 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.824
Salva come PNG Salva come JPEG
Città #
Santa Clara 427
Dublin 97
Singapore 54
Warsaw 52
Hong Kong 50
Chandler 40
Ashburn 37
Fairfield 30
Florence 22
Jakarta 19
Woodbridge 17
Moscow 16
Melbourne 15
Seattle 15
Cambridge 14
Shanghai 14
Altamura 13
Lawrence 12
Boardman 10
Helsinki 10
Houston 10
Milan 10
Mumbai 10
Wilmington 10
Vienna 9
Beijing 8
New York 8
Los Angeles 7
Pune 7
Princeton 6
Boston 5
Oslo 5
Abidjan 4
Bern 4
Kent 4
Andover 3
Ann Arbor 3
Hillsboro 3
Lappeenranta 3
London 3
Norwalk 3
Recanati 3
San Diego 3
Anguillara Sabazia 2
Bremen 2
Chennai 2
Dong Ket 2
Falls Church 2
Livorno 2
L’Aquila 2
Ottawa 2
Paris 2
Rome 2
Romola 2
Rufina 2
Taranto 2
Toronto 2
Venice 2
Yubileyny 2
Acerra 1
Ancona 1
Bagno A Ripoli 1
Bari 1
Brussels 1
Buffalo 1
Chicago 1
Enshi 1
Guangzhou 1
Harbin 1
Krefeld 1
Marcallo con Casone 1
Medford 1
Newark 1
Padova 1
Phoenix 1
Shenyang 1
Stockton 1
Verona 1
Wandsworth 1
Washington 1
Zurich 1
Totale 1.149
Salva come PNG Salva come JPEG
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 201
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 107
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 104
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 96
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 95
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment 92
Results of the observational prospective RealFLOT study 86
REBECA trial: A new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer 81
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 79
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 79
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 76
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 75
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 75
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 75
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 70
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 70
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 69
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients 64
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 64
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 59
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 45
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma 45
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 44
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors 6
Unconventional strategy could be the future: From target to KRAS broad range treatment 4
null 3
Totale 1.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 0 6 6 6 5 9 4
2020/202196 5 9 0 30 4 3 3 9 8 8 5 12
2021/202237 0 2 3 0 0 4 4 4 1 3 3 13
2022/2023308 10 36 7 27 14 53 50 39 44 7 11 10
2023/2024264 11 14 22 11 24 40 17 60 2 14 24 25
2024/20251.078 53 125 79 244 364 211 2 0 0 0 0 0
Totale 1.864